Key Developments: Merge Healthcare Inc (MRGE.O)
3.26USD
22 May 2013
$-0.04 (-1.21%)
$3.30
$3.30
$3.34
$3.23
225,850
367,112
$4.05
$2.20
Latest Key Developments (Source: Significant Developments)
Merge Healthcare Inc Reaffirms FY 2013 Guidance-Conference Call
Merge Healthcare Inc announced that the Company is on track to deliver on fiscal 2013 guidance of $265 million to $275 million of revenue and continue to expect adjusted EBITDA of 22% to 24%. The Company reported EBITDA of $52.49 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $265 million for fiscal 2013. Full Article
The Law Firm of Levi & Korsinsky, LLP Launches Investigation Into Possible Breaches Of Fiduciary Duty By Board Of Directors Of Merge Healthcare Inc
Levi & Korsinsky, LLP announced that it is investigating Merge Healthcare Inc, and its Board of Directors, in connection with possible claims of breaches of fiduciary duty. Full Article
Merge Healthcare Inc Reaffirms FY 2013 Guidance-Conference Call
Merge Healthcare Inc announced that for fiscal 2013, it expects pro forma revenue between $265 million and $275 million, and adjusted EBITDA growing to 22% to 24%. The Company reported EBITDA of $52.49 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $265 million for fiscal 2013. Full Article
Rex Hospital Selects Merge Healthcare Inc's Merge Hemo
Merge Healthcare Inc announced that Rex Hospital has implemented Merge Hemo to automate their cath lab processes into their electronic patient record. Full Article
Levi & Korsinsky, LLP Announces Investigation Of Merge Healthcare Inc
Levi & Korsinsky, LLP announced that it is investigating Merge Healthcare Inc, and its Board of Directors in connection with the compensation provided to certain of its executive officers. Full Article
Merge Healthcare Inc Explores To Sell-Reuters
Reuters reported that Merge Healthcare Inc is exploring a sale, has attracted interest from at least five private equity firms. Thoma Bravo LLC, GTCR LLC, Welsh Carson Anderson & Stowe, Francisco Partners and Avista Capital Partners are among the buyout firms that have had meetings with the Company's management and considering submitting offers this month. Merge Healthcare hopes to have offers in by November 9, 2012. Merge Healthcare, Thoma Bravo, GTCR and Avista declined to comment, while representatives of Welsh Carson Anderson & Stowe and Francisco Partners did not immediately respond to a request for comment. Full Article
Merge Healthcare Inc Issues FY 2013 Revenue Guidance; Comments On FY 2013 EBITDA Guidance
Merge Healthcare Inc announced that for fiscal 2013, it expects revenue in the range of $265 - $275 million with an adjusted EBITDA range of 22%-24%. Full Article
Merge Healthcare Inc To Explore And Evaluate Strategic Alternatives
Merge Healthcare Inc announced that Board of Directors has retained Allen & Company LLC, a New York-based investment bank, to assist in exploring and evaluating a broad range of strategic alternatives, including, but not limited to, a sale of the Company or a business combination. The Company does not have a defined timeline for the strategic review, and there can be no assurance that the review will result in any specific action or transaction. The Company does not intend to comment further regarding the evaluation of strategic alternatives, unless a definitive agreement for a specific transaction is entered into, the process is concluded, or it otherwise deems further disclosure is appropriate or required. Full Article
St. Vincent Hospital Selects Merge Healthcare Inc For End-to-End, Enterprise-Wide Cardiac Imaging And Informatics Solution
Merge Healthcare Inc. announced that St. Vincent Hospital, a hospital in Green Bay, WI and a member of the Hospital Sisters Health System, will implement Merge's complete cardiology solution suite to capture, manage and display cardiac images, and hemodynamics and ECG data across its enterprise. Full Article
Worldwide Clinical Trials Selects Merge Healthcare Inc's Merge eClinical OS to Streamline Electronic Data Capture
Merge Healthcare Inc announced that Worldwide Clinical Trials Inc. has selected Merge's eClinical OS solution to accelerate study startup, streamline electronic data capture (EDC), and maximize operational efficiency across its Phase I-IV studies. Full Article
Thoma Bravo, Francisco, THL await Merge outcome: sources
NEW YORK - Private equity firms vying for Merge Healthcare Inc are waiting for a decision from the company after the provider of medical imaging software solutions sought revised takeover offers last week, three people familiar with the matter said on Wednesday.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
